Novo Nordisk CEO Lars Fruergaard Jørgensen at a Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Sept. 24, 2024 (Graeme Sloan/Sipa USA/Sipa via AP Images)
September 24, 2024 03:10 PM EDT
Pharma
FDA+

No­vo Nordisk CEO skep­ti­cal of PBM promis­es in Sen­ate hear­ing on weight loss drug prices

Nicole DeFeudis

Editor

Sen. Bernie Sanders (I-VT) told No­vo Nordisk CEO Lars Fruer­gaard Jør­gensen that three ma­jor phar­ma­cy ben­e­fit man­agers have agreed not to pe­nal­ize the com­pa­ny for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times